Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
2023 · Nature Communications · 53 citations
https://doi.org/10.1038/s41467-023-36328-z
M
Muhammad Aminu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
575
Citations
11
h-index
11
i10-index
Muhammad Aminu is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiomics and Machine Learning in Medical Imaging & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 11, co-authored 62 publications.
ORCID: 0000-0002-9903-8812Papers by this author
worksCovid-19 detection via deep neural network and occlusion sensitivity maps
2021 · Alexandria Engineering Journal · 51 citations
https://doi.org/10.1016/j.aej.2021.03.052
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
2023 · Modern Pathology · 31 citations
https://doi.org/10.1016/j.modpat.2023.100326
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
2024 · Cell Reports Medicine · 27 citations
https://doi.org/10.1016/j.xcrm.2024.101463
CellSpatialGraph: Integrate hierarchical phenotyping and graph modeling to characterize spatial architecture in tumor microenvironment on digital pathology
2021 · Software Impacts · 4 citations
https://doi.org/10.1016/j.simpa.2021.100156
I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage Non-Small Cell Lung Cancer
2024 · International Journal of Radiation Oncology*Biology*Physics · 1 citations
https://doi.org/10.1016/j.ijrobp.2024.07.064
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat